Anthropic’s Chip Request Shakes SK Hynix’s Strategy

Anthropic has approached SK Hynix, one of the world’s largest memory chip manufacturers, seeking supplies to build its own artificial‑intelligence processors.

The Backstage of an AI Chip Initiative

At an AI summit in San Francisco, Anthropic CEO Dario Amodei sat alongside SK Hynix Group Chairman Chey Tae Won. Chey described a developer’s ambition to own its own chip as “extraordinary,” signaling the emergence of a new competitive frontier in the semiconductor arena.

SK Hynix’s Strategic Pivot

Chey Tae Won indicated that SK Group, which controls SK Hynix, is evaluating the possibility of supplying Anthropic. This move positions SK Hynix beyond memory chips, aligning it with a broader strategy to capture the AI‑centric custom silicon market.

The Korea‑US‑China Chip Triad

The request underscores the reshaping of chip capacity and supply‑chain dynamics across Asia‑Pacific. Amid the US‑China rare‑earth tug‑of‑war, South Korea finds itself both a bridge and a buffer; SK Hynix is emerging not just as a memory supplier but as a potential player in the AI processor ecosystem.

Four Key Takeaways for Investors

■AI‑driven chip demand could compress margins in the traditional memory market.

■SK Hynix aims to expand this partnership with local allies such as Nvidia and Naver.

■The Korean government is poised to offer tax breaks and R&D incentives to bolster AI chip production.

■Anthropic seeks to design its own silicon to boost model efficiency while cutting costs.

Dr. Yaman Ege – Semiconductor and Technology Supply‑Chain Director: This development signals a shift from a cost‑centric supply chain to a strategic partnership network. SK Hynix’s dominance in memory can translate into a sustainable competitive edge in the AI‑custom chip segment. However, geopolitical tensions between the US and China, coupled with rare‑earth constraints, inject uncertainty into the long‑term viability of this strategy. Investors should closely monitor both supply‑chain risks and the potential upside from R&D breakthroughs.